Tiotropium Bromide in Cystic Fibrosis (Q63829210)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tiotropium Bromide in Cystic Fibrosis |
clinical trial |
Statements
A Randomised, Double-blind, Placebo-controlled Parallel-group Trial to Confirm the Efficacy After 12 Weeks and the Safety of Tiotropium 5 Mcg Administered Once Daily Via the Respimat® Device in Patients With Cystic Fibrosis. (English)
0 references
September 2010
0 references
March 2012
0 references
464
0 references